ArticleClinical and translational medicine2026
A succinylation-based classifier predicts chemotherapy response in prostate cancer and reveals KAT2A as a therapeutic target.
Antao Dong et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.